Q702 for the Treatment of Patients With Hematologic Malignancies

Abroad (travel likely)RecruitingPHASE1

Conditions

Hematopoietic and Lymphatic System Neoplasm · Histiocytic Sarcoma · Malignant Histiocytosis · Peripheral T-Cell Lymphoma, Not Otherwise Specified · Primary Cutaneous T-Cell Non-Hodgkin Lymphoma · Recurrent Chronic Lymphocytic Leukemia · Recurrent Chronic Myelomonocytic Leukemia · Recurrent Follicular Lymphoma · Recurrent Langerhans Cell Histiocytosis · Recurrent Lymphoplasmacytic Lymphoma · Recurrent Myelodysplastic Syndrome · Recurrent Myelofibrosis · Recurrent Small Lymphocytic Lymphoma · Recurrent Waldenstrom Macroglobulinemia · Refractory Chronic Lymphocytic Leukemia · Refractory Chronic Myelomonocytic Leukemia · Refractory Erdheim-Chester Disease · Refractory Follicular Lymphoma · Refractory Langerhans Cell Histiocytosis · Refractory Lymphoplasmacytic Lymphoma · Refractory Myelodysplastic Syndrome · Refractory Myelofibrosis · Refractory Small Lymphocytic Lymphoma · Refractory Waldenstrom Macroglobulinemia · Rosai-Dorfman-Destombes Disease · Primary Central Nervous System Lymphoma · Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm · Recurrent Erdheim-Chester Disease · Recurrent Fibroblastic Reticular Cell Sarcoma · Recurrent Histiocytic Sarcoma · Recurrent Interdigitating Dendritic Cell Sarcoma · Recurrent Rosai-Dorfman-Destombes Disease · Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm · Refractory Fibroblastic Reticular Cell Sarcoma · Refractory Histiocytic Sarcoma · Refractory Interdigitating Dendritic Cell Sarcoma · Refractory Rosai-Dorfman-Destombes Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Mayo Clinic in Arizona, Scottsdale, Arizona, United States
Contact: Study coordinator (Clinical Trials Referral Office) · mayocliniccancerstudies@mayo.edu · 855-776-0015
Contact: Principal Investigator (Talal Hilal, MD)
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Contact: Study coordinator (Clinical Trials Referral Office) · mayocliniccancerstudies@mayo.edu · 855-776-0015
Contact: Principal Investigator (Jithma P. Abeykoon, MD)

Study leads

Jithma P. Abeykoon, MD
Principal Investigator
Mayo Clinic in Rochester

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

Acute Leukemia · Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE2

Seattle, United States

Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant

Leukemia · Lymphoma · Hematologic Malignancy

Abroad (travel likely)Recruiting

Bethesda, United States

Impact of an Early Warning System on the Prognosis of Patients With Hematological Malignancies Receiving Intensive Chemotherapy With or Without Hematopoietic Cell Transplantation.

Leukemia · Lymphoma · Multiple Myeloma

Abroad (travel likely)Recruiting

Amiens, France · Angers, France

Early Integration of Palliative and Supportive Care in Cellular Therapy

Leukemia · Lymphoma · Multiple Myeloma

Abroad (travel likely)Recruiting

Calgary, Canada